Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Nor Hayati Ismail"'
Autor:
Ali Mussa, Nor Hayati Ismail, Nazmul Huda Syed, Mustafa Talib, Alaa Siddig, Rosline Hassan, Rohimah Mohamud, Nik Haszroel Hysham Nik Hashim
Publikováno v:
The Microbe, Vol 5, Iss , Pp 100176- (2024)
Infection with the hepatitis B virus (HBV) has serious public health concerns. HBV infection can lead to acute hepatitis B (AHB) or chronic hepatitis B (CHB). After recovery, the viral genome (DNA) may persist for an extended period within the liver
Externí odkaz:
https://doaj.org/article/55f2700191904372995074a41a9a3d1e
Autor:
Nor Hayati Ismail, Ali Mussa, Mutaz Jamal Al-Khreisat, Shafini Mohamed Yusoff, Azlan Husin, Hamid Ali Nagi Al-Jamal, Muhammad Farid Johan, Md Asiful Islam
Publikováno v:
Non-Coding RNA, Vol 9, Iss 6, p 68 (2023)
The dysregulation of non-coding RNAs (ncRNAs), specifically microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), leads to the development and advancement of multiple myeloma (MM). miRNAs, in particular, are paramount in post-transcriptional gene re
Externí odkaz:
https://doaj.org/article/909ffedd742547c48b99e615a989dc75
Autor:
Nor Hayati Ismail, Ali Mussa, Mutaz Jamal Al-Khreisat, Shafini Mohamed Yusoff, Azlan Husin, Muhammad Farid Johan, Md Asiful Islam
Publikováno v:
Nutrients, Vol 15, Iss 14, p 3227 (2023)
Background: Multiple myeloma (MM) is a hematological malignancy characterized by the exponential growth of malignant plasma cells. Individuals diagnosed with MM exhibit a deficiency in vitamin D and may suffer fatigue, a loss of muscular strength, pe
Externí odkaz:
https://doaj.org/article/8298fe76c878414992e99bdd9435d234
Autor:
Nor Hayati Ismail, Ali Mussa, Mutaz Jamal Al-Khreisat, Shafini Mohamed Yusoff, Azlan Husin, Muhammad Farid Johan
Publikováno v:
Diagnostics, Vol 13, Iss 14, p 2328 (2023)
Multiple myeloma (MM) is an incurable hematologic malignancy. Most MM patients are diagnosed at a late stage because the early symptoms of the disease can be uncertain and nonspecific, often resembling other, more common conditions. Additionally, MM
Externí odkaz:
https://doaj.org/article/25e93fb8a59e422fbee8c42f506a8676
Autor:
Mutaz Jamal Al-Khreisat, Nor Hayati Ismail, Abedelmalek Tabnjh, Faezahtul Arbaeyah Hussain, Abdul Aziz Mohamed Yusoff, Muhammad Farid Johan, Md Asiful Islam
Publikováno v:
Diagnostics, Vol 13, Iss 12, p 2068 (2023)
Burkitt lymphoma (BL) is a form of B-cell malignancy that progresses aggressively and is most often seen in children. While Epstein–Barr virus (EBV) is a double-stranded DNA virus that has been linked to a variety of cancers, it can transform B lym
Externí odkaz:
https://doaj.org/article/03553835ba0941ecb3bd1ce2904ea50f
Autor:
Nor Hayati Ismail, Ali Mussa, Nur Atikah Zakaria, Mutaz Jamal Al-Khreisat, Muhamad Aidil Zahidin, Noor Nabila Ramli, Siti Nur Nabeela A’ifah Mohammad, Rosline Hassan, Noor Haslina Mohd Noor, Salfarina Iberahim, Zefarina Zulkafli, Shafini Mohamed Yusoff, Azlan Husin, Muhammad Farid Johan
Publikováno v:
Biomedicines, Vol 10, Iss 11, p 2767 (2022)
Multiple myeloma (MM) is an exceptionally complicated and heterogeneous disease that is caused by the abnormal proliferation of malignant monoclonal plasma cells initiated in the bone marrow. In disease progression, a multistep process including diff
Externí odkaz:
https://doaj.org/article/62796a84430f4149986c0b1b671f9bf2
Autor:
Nor Hayati Ismail, Saiful Anuar Karsani, Nadhirah Ahmad, Nazia Abdul Majid, Muhammad Zuhair Mohd Zain, Sarina Sulong
Publikováno v:
Molecular biology reports. 47(10)
Telomerase is a cancer promoting ribonucleoprotein complex and is a potential therapeutic target for cancer. In this study, the effects of telomerase downregulation on the whole cell proteome were investigated. Understanding how the effect of downreg
Autor:
Wan Khairunizam, Saiful Majid, Wan Azani Mustafa, Abu Bakar Shahriman, I. Zunaidi, M. N. Rudzuan, Mohamad Razlan Zuradzman, Nor Hayati Ismail, Basri Nor Cahyadi
Publikováno v:
AIP Conference Proceedings.
This paper investigates the muscle activation of the upper arm for the progress monitoring of post-stroke rehabilitation. The performance measure is an indicator to monitor the progress of the rehabilitation exercise. The aim is for the fast recovery